16 Best Mid Cap Growth Stocks To Buy Now
Recent discussions among financial strategists emphasize the current stock market dynamics, particularly regarding the upcoming US elections.
United Therapeutics Corp (UTHR)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 2,858,888 | $910,698,772 | 12.12% | |
| 2. | Renaissance Technologies Jim Simons | 2,174,692 | $692,748,137 | +2% | 1.17% |
| 3. | AQR Capital Management Cliff Asness | 719,510 | $229,199,910 | -16% | 0.35% |
| 4. | Palo Alto Investors William Leland Edwards | 266,914 | $85,025,455 | -1% | 9.85% |
| 5. | Eversept Partners Kamran Moghtaderi | 235,351 | $74,971,061 | -7% | 5.13% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $82.83 | 4 | Director | 1,684 | 2019-06-10 | Filing | |
| $114.06 | 6 | Director | 1,686 | 2018-04-20 | Filing | |
| $126.20 | 5 | Director | 1,685 | 2017-11-20 | Filing | |
| $128.35 | 3 | Director | 1,686 | 2017-07-28 | Filing | |
| $130.24 | 3 | Director | 1,683 | 2017-07-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $339.12 | 581 | 4,264 | 2024-09-16 | Filing | ||
| $339.12 | 562 | 3,995 | 2024-09-16 | Filing | ||
| $339.12 | 3,400 | 3,740 | 2024-09-16 | Filing | ||
| $339.12 | 3,267 | 3,740 | 2024-09-16 | Filing | ||
| $345.41 | 578 | 3,740 | 2024-09-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,295,000 | $1,164,317,551 | 0.02% | |
| 2. | 4,673,678 | $1,027,695,057 | 0.02% | |
| 3. | 3,794,010 | $834,264,860 | 0.15% | |
| 4. | 2,321,040 | $510,373,376 | 0.03% | |
| 5. | 1,947,177 | $428,164,751 | 0.02% |
News See All
United Therapeutics Corporation (NASDAQ:UTHR) Q2 2024 Earnings Call Transcript
United Therapeutics Corporation (NASDAQ:UTHR) Q2 2024 Earnings Call Transcript July 31, 2024United Therapeutics Corporation misses on earnings expectations.
30 Most Profitable Companies with Highest Margins in the World
In this article, we will be taking a look at the 30 Most Profitable Companies with Highest Margins in the World.
United Therapeutics Corporation (NASDAQ:UTHR) Q1 2024 Earnings Call Transcript
United Therapeutics Corporation beats earnings expectations. Reported EPS is $6.17, expectations were $5.65.
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
5 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
In this article, we discuss 5 most undervalued biotech stocks to buy according to hedge funds.
5 Fastest Growing Biotech Companies in the US
In this article, we will be taking a look at the 5 fastest growing biotech companies in the US.
United Therapeutics Corporation (NASDAQ:UTHR) Q4 2023 Earnings Call Transcript
United Therapeutics Corporation beats earnings expectations. Reported EPS is $4.36, expectations were $3.92.
15 Undervalued Defensive Stocks For 2024
Defensive stocks are shares of companies that remain relatively stable during economic downturns as opposed to cyclical stocks.
Jim Simons Stock Portfolio: 10 Top Stock Picks
In June this year, Stony Brook University, a public college in New York, saw the endowment fund it had swell from $370 million to more than $1 billion overnight, thanks in large part to a $500 million...
Billionaire Hedge Funds
